Current Environment: Production

Medical Services

Specialties

Programs & Services

Languages

  • English

Education

Undergraduate School

University of Scranton

2009, Scranton, PA

Medical School

Jefferson Medical College

2013, Philadelphia, PA

Internship

Pediatrics

Boston Children's Hospital

2014, Boston, MA

Residency

Pediatric Neurology

Boston Children's Hospital

2018, Boston, MA

Fellowship

Epilepsy/Clinical Neurophysiology

Boston Children's Hospital

2019, Boston, MA

Fellowship

Neuro-Immunology

Boston Children's Hospital

2020, Boston, MA

Certifications

  • American Board of Psychiatry and Neurology (Child and Adolescent Neurology)
  • American Board of Psychiatry and Neurology (Clinical Neurophysiology)

Professional History

After child neurology residency, Dr. Stredny completed fellowship training in epilepsy and neuro-immunology at Boston Children's Hospital before joining as faculty. Her clinical practice specializes in both pediatric epilepsy/seizures and autoimmune diseases of the brain and spinal cord. She is particularly interested in the overlap between these two specialties, when seizures are caused by an abnormal immune system and treated with immunotherapy. Her clinical research focuses on these disorders in which we think autoimmunity or inflammation may contribute to the generation of seizures, including Rasmussen encephalitis, febrile infection-related epilepsy syndrome (FIRES), autoimmune encephalitis, and Landau-Kleffner syndrome.

Publications

  1. Assessment of Seizure Action Plans in Pediatric Convulsive Status Epilepticus: Focus on Benzodiazepine-Responsive and Resistant Cases. Neurol Clin Pract. 2025 Jun; 15(3):e200449. View Abstract

  2. New onset refractory status epilepticus: Long-term outcomes beyond seizures. Epilepsia. 2025 Apr; 66(4):988-1005. View Abstract

  3. CIC-Related Neurodevelopmental Disorder: A Review of the Literature and an Expansion of Genotype and Phenotype. Genes (Basel). 2024 Oct 31; 15(11). View Abstract

  4. Current practices in the diagnosis and treatment of Rasmussen syndrome: Results of an international survey. Seizure. 2024 Nov; 122:153-164. View Abstract

  5. Isolated Psychiatric Symptoms in Children With Anti-N-Methyl-d Aspartate Receptor Encephalitis. Pediatr Neurol. 2024 Oct; 159:12-15. View Abstract

  6. Autoimmune-associated seizure disorders. Epileptic Disord. 2024 Aug; 26(4):415-434. View Abstract

  7. Mechanisms and Emerging Therapies for Treatment of Seizures in Pediatric Autoimmune Encephalitis and Autoinflammatory/Autoimmune-Associated Epilepsy. Rheum Dis Clin North Am. 2023 11; 49(4):875-893. View Abstract

  8. Severe, Refractory Seizures: New-Onset Refractory Status Epilepticus and Febrile Infection-Related Epilepsy Syndrome. Med Clin North Am. 2024 Jan; 108(1):201-213. View Abstract

  9. MRI Features and Their Association With Outcomes in Children With Anti-NMDA Receptor Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2023 07; 10(4). View Abstract

  10. Creation of a Novel Child Simulator and Curriculum to Optimize Administration of Seizure Rescue Medication. Simul Healthc. 2024 Oct 01; 19(5):326-332. View Abstract

  11. Long-term neuropsychological outcomes in children with febrile infection-related epilepsy syndrome (FIRES) treated with anakinra. Front Neurol. 2023; 14:1100551. View Abstract

  12. Systemic inflammation as a biomarker of seizure propensity and a target for treatment to reduce seizure propensity. Epilepsia Open. 2023 03; 8(1):221-234. View Abstract

  13. Mimics of Pediatric Small Vessel Primary Angiitis of the Central Nervous System. Ann Neurol. 2023 01; 93(1):109-119. View Abstract

  14. Development of a multidisciplinary clinical approach for unexplained regression in Down syndrome. Am J Med Genet A. 2022 08; 188(8):2509-2511. View Abstract

  15. Identifying Barriers to Care in the Pediatric Acute Seizure Care Pathway. Int J Integr Care. 2022 Jan-Mar; 22(1):28. View Abstract

  16. Infantile Hemiconvulsion-Hemiplegia and Epilepsy (IHHE) in a boy with tuberous sclerosis complex. Epilepsy Behav Rep. 2021; 16:100473. View Abstract

  17. Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort). Epilepsia. 2021 07; 62(7):1629-1642. View Abstract

  18. Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop. Epilepsia Open. 2021 03; 6(1):62-72. View Abstract

  19. Interleukin-6 Blockade With Tocilizumab in Anakinra-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES). Child Neurol Open. 2020 Jan-Dec; 7:2329048X20979253. View Abstract

  20. Anakinra usage in febrile infection related epilepsy syndrome: an international cohort. Ann Clin Transl Neurol. 2020 12; 7(12):2467-2474. View Abstract

  21. Magnetic resonance imaging-guided laser-induced thermal therapy for functional hemispherotomy in a child with refractory epilepsy and multiple medical comorbidities. J Neurosurg Pediatr. 2021 01 01; 27(1):30-35. View Abstract

  22. Seizure-related injuries in inadequately treated epilepsy patients: A case-control study. Seizure. 2020 Dec; 83:17-20. View Abstract

  23. Posterior-onset Rasmussen's encephalitis with ipsilateral cerebellar atrophy and uveitis resistant to rituximab. Epilepsy Behav Rep. 2020; 14:100360. View Abstract

  24. Pharmacotherapy for Pediatric Convulsive Status Epilepticus. CNS Drugs. 2020 01; 34(1):47-63. View Abstract

  25. Baseline and outcome assessment in pediatric status epilepticus. Seizure. 2019 May; 68:52-61. View Abstract

  26. Towards acute pediatric status epilepticus intervention teams: Do we need "Seizure Codes"? Seizure. 2018 May; 58:133-140. View Abstract

  27. Autoimmune Movement Disorders in Children. Semin Pediatr Neurol. 2018 04; 25:92-112. View Abstract

  28. Rescue Medications in Epilepsy Patients: A Family Perspective. Seizure. 2017 Nov; 52:188-194. View Abstract

  29. Vitamin B12 Deficiency Presenting with Neurological Dysfunction in an Adolescent. Pediatr Neurol. 2016 09; 62:66-70. View Abstract

  30. An improved phenylarsine oxide-affinity method identifies triose phosphate isomerase as a candidate redox receptor protein. Neurochem Res. 2010 Feb; 35(2):306-14. View Abstract

  31. Oxidative inhibition of protein phosphatase 2A activity: role of catalytic subunit disulfides. Neurochem Res. 2007 Nov; 32(11):1957-64. View Abstract

I am continually in awe of the resilience of my patients and their families. It is an honor to be a part of their team. Each day, I strive to do my best in optimizing my patients’ care and contributing to novel therapies for children with epilepsy and autoimmune disease in the future.

BESbswy